Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Unresectable Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04085250
What this trial is testing

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

Who this might be right for
Stage III Non-small-cell Lung Cancer
Sun Yat-sen University 264
Testing effectiveness (Phase 2)Active Not RecruitingNCT07005336
What this trial is testing

Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
TJ Biopharma Co., Ltd. 150
Very early researchStudy completedNCT05873439
What this trial is testing

Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC

Who this might be right for
Nonsmall Cell Lung CancerNonsmall Cell Lung Cancer, Stage IINonsmall Cell Lung Cancer Stage III+1 more
H. Lee Moffitt Cancer Center and Research Institute 3
Large-scale testing (Phase 3)Active Not RecruitingNCT03091192
What this trial is testing

Savolitinib vs. Sunitinib in MET-driven PRCC.

Who this might be right for
CarcinomaCarcinoma, Renal CellKidney Neoplasms+5 more
AstraZeneca 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04579380
What this trial is testing

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Who this might be right for
Uterine NeoplasmsUterine Cervical NeoplasmsBiliary Tract Neoplasms+3 more
Seagen, a wholly owned subsidiary of Pfizer 217
Early research (Phase 1)Looking for participantsNCT05365581
What this trial is testing

ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 398
Large-scale testing (Phase 3)Not Yet RecruitingNCT07246330
What this trial is testing

Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tianjin Medical University Cancer Institute and Hospital 340
Early research (Phase 1)Study completedNCT01199068
What this trial is testing

CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Daiichi Sankyo Co., Ltd. 15
Large-scale testing (Phase 3)Ended earlyNCT00658593
What this trial is testing

Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
NCIC Clinical Trials Group 19
Testing effectiveness (Phase 2)Study completedNCT03631784
What this trial is testing

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 216
Testing effectiveness (Phase 2)Looking for participantsNCT06900595
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

Who this might be right for
Locally Advanced Adrenal Cortical CarcinomaMetastatic Adrenal Cortical CarcinomaRecurrent Adrenal Cortical Carcinoma+3 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Looking for participantsNCT07227012
What this trial is testing

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Who this might be right for
Carcinoma, HepatocellularHepatocellular CancerHepatocellular Carcinoma+4 more
Pfizer 138
Testing effectiveness (Phase 2)Study completedNCT00078390
What this trial is testing

Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerLung CancerStage IIIA Non Small Cell Lung Cancer+1 more
Shionogi 9
Testing effectiveness (Phase 2)Looking for participantsNCT06173986
What this trial is testing

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaUnresectable Locally Advanced Esophageal Cancer
Shanghai Chest Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07519486
What this trial is testing

Intensive Nutritional Support in Conversion Therapy for Locally Advanced Unresectable ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaLocally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Sichuan University 118
Early research (Phase 1)Looking for participantsNCT05085496
What this trial is testing

Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC

Who this might be right for
Locally Advanced Skin Squamous Cell CarcinomaResectable Skin Squamous Cell CarcinomaUnresectable Skin Squamous Cell Carcinoma
City of Hope Medical Center 12
Testing effectiveness (Phase 2)WithdrawnNCT03114280
What this trial is testing

Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Centre Antoine Lacassagne
Not applicableApproved For MarketingNCT04220203
What this trial is testing

Treatment Protocol of Tucatinib With Capecitabine and Trastuzumab in Patients With Unresectable Previously Treated HER2+ Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Seagen, a wholly owned subsidiary of Pfizer
Testing effectiveness (Phase 2)Active Not RecruitingNCT05945823
What this trial is testing

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Cancer+2 more
Taiho Oncology, Inc. 53
Testing effectiveness (Phase 2)Study completedNCT03519295
What this trial is testing

MDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma

Who this might be right for
Anal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 97
Next Page